Video Experimental Relacionado
Updated: Sep 9, 2025
07:47
Experimental Human Pneumococcal Carriage
Published on: February 15, 2013
15.7K
Campaña de incentivo a la vacunación contra el neumococo en pacientes con insuficiencia cardíaca crónica en Francia:
Hugo Guillermou1, Grégoire Mercier1,2, Bernard Litovsky3
1University Hospital of Montpellier, Montpellier, France.
European journal of preventive cardiology
|August 28, 2025
Resumen
Una campaña de incentivo aumentó significativamente las tasas de vacunación neumocócica en pacientes con insuficiencia cardíaca. Esta sencilla intervención multiplicó por diez la cobertura, lo que pone de relieve su eficacia para las poblaciones de alto riesgo.
Área de la Ciencia:
- Salud pública
- La medicina preventiva
- Investigación en servicios de salud
Sus antecedentes:
- Las tasas de vacunación neumocócica son críticamente bajas en pacientes de alto riesgo, especialmente en aquellos con insuficiencia cardíaca (IF).
- Los pacientes con IH tienen un mayor riesgo de infecciones graves y complicaciones por enfermedad neumocócica.
- La evidencia de intervenciones efectivas para mejorar la absorción de la vacunación en esta población es limitada.
Objetivo del estudio:
- Evaluar el impacto de una campaña de incentivos en las tasas de vacunación neumocócica en pacientes con insuficiencia cardíaca.
- Evaluar la eficacia de una estrategia de promoción por correo aplicada por el seguro de enfermedad francés.
Principales métodos:
- Un ensayo prospectivo, abierto, pragmático, aleatorizado y controlado en el que participaron médicos generales y sus pacientes con IH crónica.
- Los pacientes fueron asignados a grupos de intervención (cartas de incentivo a médicos de cabecera y pacientes) o de control (observación).
- El objetivo primario fue la tasa de vacunación neumocócica a un año, con datos recogidos a través de la base de datos regional de seguros de salud.
Principales resultados:
- La tasa de vacunación neumocócica a un año fue del 35% en el grupo de intervención frente al 3,5% en el grupo de control.
- Los pacientes que recibieron la intervención mostraron una tasa de vacunación 15 veces mayor.
- Los factores asociados con el aumento de la vacunación incluyeron pacientes masculinos, médicos de cabecera femeninos y vacunación previa contra la influenza.
Conclusiones:
- Una promoción de incentivos por correo aumentó de manera efectiva y sostenible la cobertura de vacunación neumocócica en una población frágil y de alto riesgo de insuficiencia cardíaca.
- Esta estrategia ofrece una intervención viable de salud pública para mejorar la absorción de vacunas en grupos vulnerables.
Palabras clave:
CardiologíaLa insuficiencia cardíacaVacunas contra el neumococoLos ensayos clínicos pragmáticos como temaCobertura de la vacunaciónMás Videos Relacionados
07:41Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
Published on: March 17, 2022
3.1K
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
14.8K
Videos de Conceptos Relacionados
01:30Pneumonia V: Nursing management and Prevention
2.4K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.4K
01:28Pneumonia IV: Management
445
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
445
01:30Heart Failure V: Medical Management
23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
01:21Rheumatic Heart Disease III: Medical Management
31
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
31
01:22Heart Failure VI: Adjunct Therapies
27
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
27
01:22Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K